اخبار بازار

آخرین اخبار مالی و اقتصادی، تحولات بازار، گزارش‌ها و تحلیل‌های بازارهای مالی را در PipVero دنبال کنید.

منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Cava Group (CAVA) Registers a Bigger Fall Than the Market: Important Facts to Note

Cava Group (CAVA) Registers a Bigger Fall Than the Market: Important Facts to Note

The latest trading day saw Cava Group (CAVA) settling at $62.23, representing a -5.95% change from its previous close.

نمادهای مرتبط 1
CAVA CAVA
منبع: Zacks Investment Research
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: PRNewsWire خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit

PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit

NEW YORK, Aug. 6, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28, 2024 and February 25, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed.

نمادهای مرتبط 1
PRCT PRCT
منبع: PRNewsWire
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Affirm Holdings (AFRM) Registers a Bigger Fall Than the Market: Important Facts to Note

Affirm Holdings (AFRM) Registers a Bigger Fall Than the Market: Important Facts to Note

Affirm Holdings (AFRM) closed at $76.58 in the latest trading session, marking a -2.41% move from the prior day.

نمادهای مرتبط 1
AFRM AFRM
منبع: Zacks Investment Research
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
NetApp (NTAP) Increases Despite Market Slip: Here's What You Need to Know

NetApp (NTAP) Increases Despite Market Slip: Here's What You Need to Know

NetApp (NTAP) closed at $191.48 in the latest trading session, marking a +2.62% move from the prior day.

نمادهای مرتبط 1
NTAP NTAP
منبع: Zacks Investment Research
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Here's Why Lithium Americas Corp. (LAC) Fell More Than Broader Market

Here's Why Lithium Americas Corp. (LAC) Fell More Than Broader Market

Lithium Americas Corp. (LAC) reached $3.02 at the closing of the latest trading day, reflecting a -2.27% change compared to its last close.

نمادهای مرتبط 1
LAC LAC
منبع: Zacks Investment Research
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
10x Genomics (TXG) Reports Q2 Loss, Tops Revenue Estimates

10x Genomics (TXG) Reports Q2 Loss, Tops Revenue Estimates

10x Genomics (TXG) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to earnings of $0.28 per share a year ago.

نمادهای مرتبط 1
TXG TXG
منبع: Zacks Investment Research
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
QuidelOrtho (QDEL) Surpasses Q2 Earnings and Revenue Estimates

QuidelOrtho (QDEL) Surpasses Q2 Earnings and Revenue Estimates

QuidelOrtho (QDEL) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to earnings of $0.12 per share a year ago.

نمادهای مرتبط 1
QDEL QDEL
منبع: Zacks Investment Research
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Gen Digital (GEN) Beats Q1 Earnings and Revenue Estimates

Gen Digital (GEN) Beats Q1 Earnings and Revenue Estimates

Gen Digital (GEN) came out with quarterly earnings of $0.71 per share, beating the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $0.64 per share a year ago.

نمادهای مرتبط 1
GEN GEN
منبع: Zacks Investment Research
مشاهده منبع
Official Partner ITBFX Start Trading
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Halozyme Therapeutics (HALO) Q2 Earnings and Revenues Surpass Estimates

Halozyme Therapeutics (HALO) Q2 Earnings and Revenues Surpass Estimates

Halozyme Therapeutics (HALO) came out with quarterly earnings of $2.28 per share, beating the Zacks Consensus Estimate of $1.82 per share. This compares to earnings of $1.54 per share a year ago.

نمادهای مرتبط 1
HALO HALO
منبع: Zacks Investment Research
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Janux Therapeutics, Inc. (JANX) Reports Q2 Loss, Lags Revenue Estimates

Janux Therapeutics, Inc. (JANX) Reports Q2 Loss, Lags Revenue Estimates

Janux Therapeutics, Inc. (JANX) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to a loss of $0.55 per share a year ago.

نمادهای مرتبط 1
JANX JANX
منبع: Zacks Investment Research
مشاهده منبع
Official Partner ITBFX Start Trading
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Airbnb, Inc. (ABNB) Beats Q2 Earnings and Revenue Estimates

Airbnb, Inc. (ABNB) Beats Q2 Earnings and Revenue Estimates

Airbnb, Inc. (ABNB) came out with quarterly earnings of $1.37 per share, beating the Zacks Consensus Estimate of $1.2 per share. This compares to earnings of $1.03 per share a year ago.

نمادهای مرتبط 1
ABNB ABNB
منبع: Zacks Investment Research
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Arcturus Therapeutics (ARCT) Reports Q2 Loss, Beats Revenue Estimates

Arcturus Therapeutics (ARCT) Reports Q2 Loss, Beats Revenue Estimates

Arcturus Therapeutics (ARCT) came out with a quarterly loss of $0.84 per share versus the Zacks Consensus Estimate of a loss of $1.07. This compares to a loss of $0.34 per share a year ago.

نمادهای مرتبط 1
ARCT ARCT
منبع: Zacks Investment Research
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Doximity (DOCS) Q1 Earnings Lag Estimates

Doximity (DOCS) Q1 Earnings Lag Estimates

Doximity (DOCS) came out with quarterly earnings of $0.29 per share, missing the Zacks Consensus Estimate of $0.3 per share. This compares to earnings of $0.36 per share a year ago.

نمادهای مرتبط 1
DOCS DOCS
منبع: Zacks Investment Research
مشاهده منبع
Official Partner ITBFX Start Trading
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
The Trade Desk (TTD) Misses Q2 Earnings and Revenue Estimates

The Trade Desk (TTD) Misses Q2 Earnings and Revenue Estimates

The Trade Desk (TTD) came out with quarterly earnings of $0.34 per share, missing the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.41 per share a year ago.

نمادهای مرتبط 1
TTD TTD
منبع: Zacks Investment Research
مشاهده منبع
0 0 0
ادامه مطلب
نظر